Aemetis, Inc. (NASDAQ:AMTX) Sees Large Growth in Short Interest

Aemetis, Inc. (NASDAQ:AMTX) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 5,320,000 shares, an increase of 14.7% from the March 15th total of 4,640,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the days-to-cover ratio is presently 4.4 days.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on AMTX shares. Truist Financial dropped their price target on Aemetis from $5.00 to $3.50 and set a “hold” rating on the stock in a research note on Tuesday, January 23rd. Stifel Nicolaus lowered their target price on Aemetis from $8.00 to $6.50 and set a “buy” rating on the stock in a research report on Wednesday, February 21st.

Aemetis Trading Down 1.2 %

NASDAQ AMTX traded down $0.05 on Tuesday, reaching $4.03. The company had a trading volume of 377,998 shares, compared to its average volume of 1,157,258. The company’s fifty day moving average is $4.08 and its 200 day moving average is $4.34. Aemetis has a 52-week low of $1.16 and a 52-week high of $8.99.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.01. The business had revenue of $70.76 million for the quarter, compared to the consensus estimate of $80.08 million. During the same quarter in the previous year, the firm earned ($0.63) earnings per share. On average, analysts predict that Aemetis will post -1.44 EPS for the current fiscal year.

Institutional Investors Weigh In On Aemetis

A number of hedge funds have recently made changes to their positions in the business. Point72 Asset Management L.P. purchased a new position in Aemetis during the 2nd quarter valued at about $25,000. Barclays PLC grew its holdings in shares of Aemetis by 542.0% during the fourth quarter. Barclays PLC now owns 8,031 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 6,780 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Aemetis by 173.7% during the third quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 3,545 shares in the last quarter. Deutsche Bank AG grew its holdings in shares of Aemetis by 66.9% during the first quarter. Deutsche Bank AG now owns 18,454 shares of the specialty chemicals company’s stock worth $43,000 after purchasing an additional 7,395 shares in the last quarter. Finally, BNP Paribas Arbitrage SA grew its holdings in shares of Aemetis by 105.6% during the second quarter. BNP Paribas Arbitrage SA now owns 9,517 shares of the specialty chemicals company’s stock worth $47,000 after purchasing an additional 4,887 shares in the last quarter. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.